Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methadone Versus Standard of Care for Pain Control in Minimally Invasive Lung Resection Surgery

NCT07914751 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT07914751 Not yet recruiting Phase 4 150 participants (estimated) Started 2026 1 site

Follow this trial by email Email me the PDF

Get the NCT07914751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Summary

Not yet recruiting, started December 2026. Interventional study, Phase 4, 150 participants (estimated). Lead sponsor Wake Forest University Health Sciences; United States. Primary measures: Morphine Milligram Equivalents-24; Morphine Milligram Equivalents-48 and 4 more.

How it compares

433 similar trials: same condition (Agnosia) and phase

Enrollment

This trial
150
Middle half
40 to 115
Median
72
Trials with a value
432

Months from start to completion

This trial
18
Middle half
8.6 to 28
Median
18
Trials with a value
427

Sites

This trial
1
Middle half
1 to 1
Median
1
Trials with a value
391
Posted results or a linked paper 58% 250 of 433 similar trials; this trial: no

Registry record

As filed in ClinicalTrials.gov.

Title
Methadone Versus Standard of Care for Pain Control in Minimally Invasive Lung Resection Surgery
Lead sponsor
Wake Forest University Health Sciences
Phase
Phase 4
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
June 30, 2028
Enrollment
150 (estimated)
Sites
1

Conditions

MeSH condition names; the registry's own terms follow.

Agnosia

Registry terms: pain management

Who could take part, where it ran, who ran it

As filed in ClinicalTrials.gov.

Sex
All
Minimum age
18 Years
Healthy volunteers
No
Study type
Interventional
Sites
1
Countries
United States
Lead sponsor
Wake Forest University Health Sciences

Arms

As registered; 2 arms.

Registered arms
Arm Type Interventions
Methadone Experimental Methadone
Show registry wording

Analgesia with methadone. Other analgesic medications may also be given.

Standard of Care Active comparator Standard of Care
Show registry wording

Patients in the standard of care group may receive any analgesic at discretion of the anesthesia team but may not receive methadone.

Primary endpoints

Registered primary outcome measures; 6 primary.

Registered primary endpoints
Measure Time frame
Morphine Milligram Equivalents-24 Postoperative Hour 24
Show registry wording

opioids received for the treatment of postoperative pain and converted to Morphine Milligram Equivalents equivalents between HR 0-24 during hospitalization

Morphine Milligram Equivalents-48 Postoperative Hour 48
Show registry wording

opioids received for the treatment of postoperative pain and converted to Morphine Milligram Equivalents (MME) between hour 24-48. If subjects have been discharged then only the available data will be used for conversion of MMEs.

Morphine Milligram Equivalents-72 Postoperative Hour 72
Show registry wording

opioids received for the treatment of postoperative pain and converted to Morphine Milligram Equivalents (MME) between hour 48-72. If subjects have been discharged then only the available data will be used for conversion of MMEs.

Pain Score Postoperative Hour 24
Show registry wording

Participants will rate their pain level on a scale of 0-10 with 0 being no pain and 10 the worst imaginable pain.

Pain Score Postoperative Hour 48
Show registry wording

Participants will rate their pain level on a scale of 0-10 with 0 being no pain and 10 the worst imaginable pain. If subjects have been discharged then only the available data will be used.

+1 more primary endpoint

Lead sponsor's other trials

Wake Forest University Health Sciences, most recent start first.

Similar trials

Same condition (Agnosia) and phase, most recent start first.